Report cover image

Global Topical Analgesics Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 198 Pages
SKU # APRC20557404

Description

Summary

According to APO Research, the global Topical Analgesics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Topical Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Topical Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Topical Analgesics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Topical Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Topical Analgesics market include Sanofi, Johnson & Johnson, Novartis, Mylan, GSK, Topical BioMedics, THE PURE SOURCE, Teikoku Seiyaku and Qizheng, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Topical Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Topical Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Topical Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Topical Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Topical Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Topical Analgesics sales, projected growth trends, production technology, application and end-user industry.

Topical Analgesics Segment by Company

Sanofi
Johnson & Johnson
Novartis
Mylan
GSK
Topical BioMedics
THE PURE SOURCE
Teikoku Seiyaku
Qizheng
Mercury Healthcare
Lingrui
Huarun 999
Hisamitsu
Endo
Actavis
Topical Analgesics Segment by Type

Pain Relief Patches
Analgesic Creams
Analgesic Sprays
Topical Analgesics Segment by Application

Muscle Pain
Arthritis Pain
Topical Analgesics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Topical Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Topical Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Topical Analgesics significant trends, drivers, influence factors in global and regions.
6. To analyze Topical Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Topical Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Analgesics industry.
Chapter 3: Detailed analysis of Topical Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Topical Analgesics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Topical Analgesics Sales Value (2020-2031)
1.2.2 Global Topical Analgesics Sales Volume (2020-2031)
1.2.3 Global Topical Analgesics Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Topical Analgesics Market Dynamics
2.1 Topical Analgesics Industry Trends
2.2 Topical Analgesics Industry Drivers
2.3 Topical Analgesics Industry Opportunities and Challenges
2.4 Topical Analgesics Industry Restraints
3 Topical Analgesics Market by Company
3.1 Global Topical Analgesics Company Revenue Ranking in 2024
3.2 Global Topical Analgesics Revenue by Company (2020-2025)
3.3 Global Topical Analgesics Sales Volume by Company (2020-2025)
3.4 Global Topical Analgesics Average Price by Company (2020-2025)
3.5 Global Topical Analgesics Company Ranking (2023-2025)
3.6 Global Topical Analgesics Company Manufacturing Base and Headquarters
3.7 Global Topical Analgesics Company Product Type and Application
3.8 Global Topical Analgesics Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Topical Analgesics Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Topical Analgesics Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Topical Analgesics Market by Type
4.1 Topical Analgesics Type Introduction
4.1.1 Pain Relief Patches
4.1.2 Analgesic Creams
4.1.3 Analgesic Sprays
4.2 Global Topical Analgesics Sales Volume by Type
4.2.1 Global Topical Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Topical Analgesics Sales Volume by Type (2020-2031)
4.2.3 Global Topical Analgesics Sales Volume Share by Type (2020-2031)
4.3 Global Topical Analgesics Sales Value by Type
4.3.1 Global Topical Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Topical Analgesics Sales Value by Type (2020-2031)
4.3.3 Global Topical Analgesics Sales Value Share by Type (2020-2031)
5 Topical Analgesics Market by Application
5.1 Topical Analgesics Application Introduction
5.1.1 Muscle Pain
5.1.2 Arthritis Pain
5.2 Global Topical Analgesics Sales Volume by Application
5.2.1 Global Topical Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Topical Analgesics Sales Volume by Application (2020-2031)
5.2.3 Global Topical Analgesics Sales Volume Share by Application (2020-2031)
5.3 Global Topical Analgesics Sales Value by Application
5.3.1 Global Topical Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Topical Analgesics Sales Value by Application (2020-2031)
5.3.3 Global Topical Analgesics Sales Value Share by Application (2020-2031)
6 Topical Analgesics Regional Sales and Value Analysis
6.1 Global Topical Analgesics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Topical Analgesics Sales by Region (2020-2031)
6.2.1 Global Topical Analgesics Sales by Region: 2020-2025
6.2.2 Global Topical Analgesics Sales by Region (2026-2031)
6.3 Global Topical Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Topical Analgesics Sales Value by Region (2020-2031)
6.4.1 Global Topical Analgesics Sales Value by Region: 2020-2025
6.4.2 Global Topical Analgesics Sales Value by Region (2026-2031)
6.5 Global Topical Analgesics Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Topical Analgesics Sales Value (2020-2031)
6.6.2 North America Topical Analgesics Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Topical Analgesics Sales Value (2020-2031)
6.7.2 Europe Topical Analgesics Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Topical Analgesics Sales Value (2020-2031)
6.8.2 Asia-Pacific Topical Analgesics Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Topical Analgesics Sales Value (2020-2031)
6.9.2 South America Topical Analgesics Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Topical Analgesics Sales Value (2020-2031)
6.10.2 Middle East & Africa Topical Analgesics Sales Value Share by Country, 2024 VS 2031
7 Topical Analgesics Country-level Sales and Value Analysis
7.1 Global Topical Analgesics Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Topical Analgesics Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Topical Analgesics Sales by Country (2020-2031)
7.3.1 Global Topical Analgesics Sales by Country (2020-2025)
7.3.2 Global Topical Analgesics Sales by Country (2026-2031)
7.4 Global Topical Analgesics Sales Value by Country (2020-2031)
7.4.1 Global Topical Analgesics Sales Value by Country (2020-2025)
7.4.2 Global Topical Analgesics Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Topical Analgesics Sales Value Growth Rate (2020-2031)
7.5.2 USA Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Topical Analgesics Sales Value Growth Rate (2020-2031)
7.6.2 Canada Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Topical Analgesics Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Topical Analgesics Sales Value Growth Rate (2020-2031)
7.8.2 Germany Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Topical Analgesics Sales Value Growth Rate (2020-2031)
7.9.2 France Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.9.3 France Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Topical Analgesics Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Topical Analgesics Sales Value Growth Rate (2020-2031)
7.11.2 Italy Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Topical Analgesics Sales Value Growth Rate (2020-2031)
7.12.2 Spain Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Topical Analgesics Sales Value Growth Rate (2020-2031)
7.13.2 Russia Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Topical Analgesics Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Topical Analgesics Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Topical Analgesics Sales Value Growth Rate (2020-2031)
7.16.2 China Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.16.3 China Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Topical Analgesics Sales Value Growth Rate (2020-2031)
7.17.2 Japan Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Topical Analgesics Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Topical Analgesics Sales Value Growth Rate (2020-2031)
7.19.2 India Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.19.3 India Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Topical Analgesics Sales Value Growth Rate (2020-2031)
7.20.2 Australia Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Topical Analgesics Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Topical Analgesics Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Topical Analgesics Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Topical Analgesics Sales Value Growth Rate (2020-2031)
7.24.2 Chile Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Topical Analgesics Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Topical Analgesics Sales Value Growth Rate (2020-2031)
7.26.2 Peru Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Topical Analgesics Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Topical Analgesics Sales Value Growth Rate (2020-2031)
7.28.2 Israel Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Topical Analgesics Sales Value Growth Rate (2020-2031)
7.29.2 UAE Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Topical Analgesics Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Topical Analgesics Sales Value Growth Rate (2020-2031)
7.31.2 Iran Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Topical Analgesics Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Topical Analgesics Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Topical Analgesics Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Topical Analgesics Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.1.4 Sanofi Topical Analgesics Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Topical Analgesics Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.3.4 Novartis Topical Analgesics Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.4.4 Mylan Topical Analgesics Product Portfolio
8.4.5 Mylan Recent Developments
8.5 GSK
8.5.1 GSK Comapny Information
8.5.2 GSK Business Overview
8.5.3 GSK Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.5.4 GSK Topical Analgesics Product Portfolio
8.5.5 GSK Recent Developments
8.6 Topical BioMedics
8.6.1 Topical BioMedics Comapny Information
8.6.2 Topical BioMedics Business Overview
8.6.3 Topical BioMedics Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.6.4 Topical BioMedics Topical Analgesics Product Portfolio
8.6.5 Topical BioMedics Recent Developments
8.7 THE PURE SOURCE
8.7.1 THE PURE SOURCE Comapny Information
8.7.2 THE PURE SOURCE Business Overview
8.7.3 THE PURE SOURCE Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.7.4 THE PURE SOURCE Topical Analgesics Product Portfolio
8.7.5 THE PURE SOURCE Recent Developments
8.8 Teikoku Seiyaku
8.8.1 Teikoku Seiyaku Comapny Information
8.8.2 Teikoku Seiyaku Business Overview
8.8.3 Teikoku Seiyaku Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.8.4 Teikoku Seiyaku Topical Analgesics Product Portfolio
8.8.5 Teikoku Seiyaku Recent Developments
8.9 Qizheng
8.9.1 Qizheng Comapny Information
8.9.2 Qizheng Business Overview
8.9.3 Qizheng Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.9.4 Qizheng Topical Analgesics Product Portfolio
8.9.5 Qizheng Recent Developments
8.10 Mercury Healthcare
8.10.1 Mercury Healthcare Comapny Information
8.10.2 Mercury Healthcare Business Overview
8.10.3 Mercury Healthcare Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.10.4 Mercury Healthcare Topical Analgesics Product Portfolio
8.10.5 Mercury Healthcare Recent Developments
8.11 Lingrui
8.11.1 Lingrui Comapny Information
8.11.2 Lingrui Business Overview
8.11.3 Lingrui Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.11.4 Lingrui Topical Analgesics Product Portfolio
8.11.5 Lingrui Recent Developments
8.12 Huarun 999
8.12.1 Huarun 999 Comapny Information
8.12.2 Huarun 999 Business Overview
8.12.3 Huarun 999 Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.12.4 Huarun 999 Topical Analgesics Product Portfolio
8.12.5 Huarun 999 Recent Developments
8.13 Hisamitsu
8.13.1 Hisamitsu Comapny Information
8.13.2 Hisamitsu Business Overview
8.13.3 Hisamitsu Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.13.4 Hisamitsu Topical Analgesics Product Portfolio
8.13.5 Hisamitsu Recent Developments
8.14 Endo
8.14.1 Endo Comapny Information
8.14.2 Endo Business Overview
8.14.3 Endo Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.14.4 Endo Topical Analgesics Product Portfolio
8.14.5 Endo Recent Developments
8.15 Actavis
8.15.1 Actavis Comapny Information
8.15.2 Actavis Business Overview
8.15.3 Actavis Topical Analgesics Sales, Value and Gross Margin (2020-2025)
8.15.4 Actavis Topical Analgesics Product Portfolio
8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Topical Analgesics Value Chain Analysis
9.1.1 Topical Analgesics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Topical Analgesics Sales Mode & Process
9.2 Topical Analgesics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Topical Analgesics Distributors
9.2.3 Topical Analgesics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.